AAAAAA

   
Results: 1-9 |
Results: 9
Characterization of a new monoclonal antibody 6G7 that recognizes a uniqueantigen on myeloid and lymphoid cells
Authors: Chen, J Zhou, JH Ball, ED
Citation: J. Chen et al., Characterization of a new monoclonal antibody 6G7 that recognizes a uniqueantigen on myeloid and lymphoid cells, J HEMATH ST, 10(2), 2001, pp. 237-246
Cytotoxicity of anti-CD64-ricin A chain immunotoxin against human acute myeloid leukemia cells in vitro and in SCID mice
Authors: Zhong, RK Van De Winkel, JGJ Thepen, T Schultz, LD Ball, ED
Citation: Rk. Zhong et al., Cytotoxicity of anti-CD64-ricin A chain immunotoxin against human acute myeloid leukemia cells in vitro and in SCID mice, J HEMATH ST, 10(1), 2001, pp. 95-105
Caution in the use of 2-iminothiolane (Traut's reagent) as a cross-linkingagent for peptides. The formation of N-peptidyl-2-iminothiolanes with bombesin (BN) antagonist (D-Trp(6),Leu(13)-psi[CH2NH]-Phe(14))BN6-14 and D-Trp-Gln-Trp-NH2
Authors: Mokotoff, M Mocarski, YM Gentsch, BL Miller, MR Zhou, JH Chen, J Ball, ED
Citation: M. Mokotoff et al., Caution in the use of 2-iminothiolane (Traut's reagent) as a cross-linkingagent for peptides. The formation of N-peptidyl-2-iminothiolanes with bombesin (BN) antagonist (D-Trp(6),Leu(13)-psi[CH2NH]-Phe(14))BN6-14 and D-Trp-Gln-Trp-NH2, J PEPT RES, 57(5), 2001, pp. 383-389
Beneficial effect of intravenous lidocaine in cutaneous chronic graft-versus-host disease secondary to donor lymphocyte infusion
Authors: Voltarelli, JC Ahmed, H Paton, EJA Stracieri, ABPL Holman, P Bashey, A Coutinho, M Simoes, BP Ball, ED Carrier, E
Citation: Jc. Voltarelli et al., Beneficial effect of intravenous lidocaine in cutaneous chronic graft-versus-host disease secondary to donor lymphocyte infusion, BONE MAR TR, 28(1), 2001, pp. 97-99
Direct effect of bispecific anti-CD33 x anti-CD64 antibody on proliferation and signaling in myeloid cells
Authors: Balaian, L Ball, ED
Citation: L. Balaian et Ed. Ball, Direct effect of bispecific anti-CD33 x anti-CD64 antibody on proliferation and signaling in myeloid cells, LEUK RES, 25(12), 2001, pp. 1115-1125
Simultaneous administration of G-CSF and GM-CSF for re-mobilization in patients with inadequate initial progenitol cell collections for autologous transplantation
Authors: Bashey, A Corringham, S Gilpin, E Fields, KK Smilee, RC DeFrancisco, C Santos-Ada, O Holman, P Carrier, E Ho, AD Lane, TA Ball, ED Janssen, WE Law, P
Citation: A. Bashey et al., Simultaneous administration of G-CSF and GM-CSF for re-mobilization in patients with inadequate initial progenitol cell collections for autologous transplantation, CYTOTHERAPY, 2(3), 2000, pp. 195-200
Autologous bone marrow transplantation for acute myeloid leukemia in remission or first relapse using monoclonal antibody-purged marrow: results of phase II studies with long-term follow-up
Authors: Ball, ED Wilson, J Phelps, V Neudorf, S
Citation: Ed. Ball et al., Autologous bone marrow transplantation for acute myeloid leukemia in remission or first relapse using monoclonal antibody-purged marrow: results of phase II studies with long-term follow-up, BONE MAR TR, 25(8), 2000, pp. 823-829
Ex vivo purging and cell expansion
Authors: Ball, ED
Citation: Ed. Ball, Ex vivo purging and cell expansion, J HEMATH ST, 8(5), 1999, pp. 457-458
Human blood dendritic cell-like B cells isolated by the 5G9 monoclonal antibody reactive with a novel 220-kDa antigen
Authors: Zhong, RK Donnenberg, AD Zhang, HF Watkins, S Zhou, JH Ball, ED
Citation: Rk. Zhong et al., Human blood dendritic cell-like B cells isolated by the 5G9 monoclonal antibody reactive with a novel 220-kDa antigen, J IMMUNOL, 163(3), 1999, pp. 1354-1362
Risultati: 1-9 |